DrugDashboards

Lidocaine Hydrochloride and Dextrose

LIDOCAINE HYDROCHLORIDE ANHYDROUS and DEXTROSE MONOHYDRATE · LIDOCAINE HYDROCHLORIDE ANHYDROUS .4 g/100mL; DEXTROSE MONOHYDRATE 5 g/100mL · Injection, Solution · Intravenous · ProPharma Distribution

NDC 84549-0594-20 · 250 mL in 1 CONTAINER · NDA · View full market →

The short version

Just 2 companies supply this market — thin enough that a single exit would be felt immediately. It is in shortage right now.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
NDA019830
TE code
AP
Approval date
Apr 8, 1992
Patents / exclusivity
None on file

Shortage history

  • In shortage now — Lidocaine Hydrochloride And Dextrose, Injection, 5 g/100 mL; .4 g/100 mL (NDC 0264-9594-10)Oct 25, 2017
    month 107 — 5× the typical 20-month injectable shortage
  • In shortage now — Lidocaine Hydrochloride And Dextrose, Injection, 5 g/100 mL; .4 g/100 mL (NDC 0264-9594-20)Oct 25, 2017
    month 107 — 5× the typical 20-month injectable shortage
  • In shortage now — Lidocaine Hydrochloride And Dextrose, Injection, 5 g/100 mL; .8 g/100 mL (NDC 0264-9598-20)Oct 25, 2017
    month 107 — 5× the typical 20-month injectable shortage

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of LIDOCAINE HYDROCHLORIDE ANHYDROUS and DEXTROSE MONOHYDRATE (Injection, Solution)

LabelerStrengthFirst seenLast seen
B. Braun Medical Inc.LIDOCAINE HYDROCHLORIDE ANHYDROUS .4 g/100mL; DEXTROSE MONOHYDRATE 5 g/100mLAug 26, 2026Sep 2, 2026
B. Braun Medical Inc.LIDOCAINE HYDROCHLORIDE ANHYDROUS .8 g/100mL; DEXTROSE MONOHYDRATE 5 g/100mLAug 26, 2026Sep 2, 2026
ProPharma DistributionLIDOCAINE HYDROCHLORIDE ANHYDROUS .4 g/100mL; DEXTROSE MONOHYDRATE 5 g/100mLAug 26, 2026Sep 2, 2026
B. Braun Medical Inc.LIDOCAINE HYDROCHLORIDE ANHYDROUS 5 g/100mL; DEXTROSE MONOHYDRATE .8 g/100mLJul 22, 2026Aug 19, 2026
B. Braun Medical Inc.LIDOCAINE HYDROCHLORIDE ANHYDROUS 5 g/100mL; DEXTROSE MONOHYDRATE .4 g/100mLJul 22, 2026Aug 19, 2026
ProPharma DistributionLIDOCAINE HYDROCHLORIDE ANHYDROUS 5 g/100mL; DEXTROSE MONOHYDRATE .4 g/100mLJul 22, 2026Aug 19, 2026
B. Braun Medical Inc.DEXTROSE MONOHYDRATE 5 g/100mL; LIDOCAINE HYDROCHLORIDE ANHYDROUS .4 g/100mLJul 15, 2026Jul 15, 2026
B. Braun Medical Inc.DEXTROSE MONOHYDRATE 5 g/100mL; LIDOCAINE HYDROCHLORIDE ANHYDROUS .8 g/100mLJul 15, 2026Jul 15, 2026
ProPharma DistributionDEXTROSE MONOHYDRATE 5 g/100mL; LIDOCAINE HYDROCHLORIDE ANHYDROUS .4 g/100mLJul 15, 2026Jul 15, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Lidocaine Hydrochloride and Dextrose — NDC 84549-0594-20," retrieved September 3, 2026, https://drugdashboards.com/drug/84549059420.

Free to cite with attribution — see how the data is put together.